DOCSLIB.ORG

Cellular Distribution of Torsin a and Torsin B in Normal Human Brain

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Cellular Distribution of Torsin a and Torsin B in Normal Human Brain ORIGINAL CONTRIBUTION Cellular Distribution of Torsin A and Torsin B in Normal Human Brain Marina Konakova, PhD; Duong P. Huynh, PhD; William Yong, MD; Stefan M. Pulst, MD Background: Early-onset torsion dystonia is a hyper- teins. In Western blot analysis of normal human brain kinetic movement disorder caused by a deletion of 1 glu- homogenates, the antibodies specifically recognized 38-kd tamic acid residue in torsin A protein, a novel member endogenous torsin A and 62-kd endogenous torsin B. Ab- of the AAA family of adenosine triphosphatases. No mu- sorption controls showed that labeling was blocked by tation has been found so far in the closely related torsin cognate peptide used for immunization. Immunolocal- B protein. Little is known about the molecular basis of ization studies revealed that torsin A and torsin B were the disease, and the cellular functions of torsin proteins widely expressed throughout the human central ner- remain to be investigated. vous system. Both proteins displayed cytoplasmic dis- tribution, although torsin B localization in some neu- Objective: To study the regional, cellular, and subcel- rons was perinuclear. Strong labeling of neuronal lular distribution of the torsin A and torsin B proteins. processes was detected for both proteins. Methods: Expression of torsin proteins in the central Conclusions: Torsin A and torsin B have similar distri- nervous system was analyzed by Western blot analysis bution in the central nervous system, although their sub- and immunohistochemistry in human postmortem brain cellular localization is not identical. Strong expression tissues. in neuronal processes points to a potential role for tor- sin proteins in synaptic functioning. Results: We generated polyclonal antipeptide antibod- ies directed against human torsin A and torsin B pro- Arch Neurol. 2001;58:921-927 RIMARY EARLY-ONSET torsion Despite significant progress in un- dystonia is an autosomal derstanding the genetic basis of early- dominant inherited disorder onset torsion dystonia, the molecular that has been linked to the ge- mechanism by which this mutation re- netic locus DYT1 on human sults in the disease phenotype is not well chromosomeP 9q34.1,2 Two genes from this understood. The process is thought to in- locus (TOR1A and TOR1B) have been re- volve a deficiency in dopamine release in cently identified through positional clon- the substantia nigra.5,6 To address the mo- ing.3,4 The TOR1A gene encodes a 37-kd lecular mechanisms of early-onset dysto- protein called torsin A. The adjacentTOR1B nia, several studies have examined the ana- gene encodes a closely related protein called tomical distribution of torsin proteins in torsin B of unknown molecular weight. A the central nervous system (CNS). One of GAG deletion at codon 302 in torsin A re- these studies focused on the expression of sults in loss of 1 glutamic acid and causes torsin A and torsin B messenger RNA disease, although penetrance of this mu- (mRNA) expression in the normal hu- tant allele is only 30%. man brain7—torsin A mRNA was found Sequence analysis of the complemen- in many brain regions, including the do- From the Rose Moss Laboratory tary DNA encoding torsin A and torsin B pamine neurons of the substantia nigra; for Parkinson’s and indicated that these proteins belong to the however, no expression of torsin B mRNA Neurodegenerative Diseases, AAA family of adenosine triphosphatases was detected in the same regions. One Burns and Allen Research (ATPases), associated with diverse cellu- study examined the expression of torsin Institute (Drs Konakova, lar activities. This family of ATPases is de- A protein in the frontal cortex, cerebel- Huynh, and Pulst), the fined by a conserved ATPase domain that lum, and substantia nigra of rat and hu- Department of Surgical 8 Pathology (Dr Yong), and the contains Walker homology sequences. man brains. Localization was nuclear and Division of Neurology Since AAA-type ATPases are implicated in cytoplasmic in neurons; the distribution (Dr Pulst), Cedars-Sinai a wide variety of functions, it is difficult of torsin B protein was not analyzed. Medical Center, UCLA School to predict what cellular processes in- Nuclear localization of torsin A in this of Medicine, Los Angeles, Calif. volve the torsin proteins. study did not correspond to cytoplasmic (REPRINTED) ARCH NEUROL / VOL 58, JUNE 2001 WWW.ARCHNEUROL.COM 921 Downloaded from www.archneurol.com at University of Utah, on March 29, 2012 ©2001 American Medical Association. All rights reserved. METHODS GEL ELECTROPHORESIS AND WESTERN BLOTTING Cell lysates were mixed with an equal volume of 2X load- PREPARATION OF ing buffer (135-mmol/L Tris hydrochloride, pH 6.8; 20% ANTIPEPTIDE ANTIBODIES glycerol; 4% sodium dodecyl sulfate; 5% 2-mercaptoetha- nol; and 0.0025% bromphenol blue) and subjected to one- Antisera against human torsin A and B were generated by dimensional sodium dodecly sulfate–polyacrylamide gel immunizing rabbits with synthetic peptides conjugated to electrophoresis (4%-15% acrylamide gels) according to the keyhole limpet hemocyanin. These peptides were synthe- method of Laemmli.11 sized with a COOH-terminal cysteine. Synthetic peptides After electrophoresis, proteins were transferred to a ni- used for immunization were as follows: peptide 1 trocellulosemembrane(AmershamPharmaciaBiotech)intrans- (GQKRSLSREALQK [residues 51-65]) and peptide 2 fer buffer (25-mmol/L Tris, 192-mmol/L glycine, and 20% (SGKQREDIKLKDIE [residues 224-237]) of human tor- methanol)usingatankblotapparatus.Blotswerestainedwith sin A and peptide 3 (HEQKIKLYQDQLQK [residues 77- PonceauStoverifyequalproteinloadingperlane.After1hour 90]) of human torsin B. of blocking using 5% nonfat milk powder in Tris-buffered salinewithTween(20-mmol/LTris-hydrochloride,pH7.6;137- AFFINITY PURIFICATION mmol/L sodium chloride; and 0.05% Tween 20), blots were OF ANTIBODIES probedwithantibodies(1or2µg/mLdilutedinTris-buffered salinewithTweencontaining5%milkpowder)overnight.The Individual peptides were coupled to cyanogen bromide– primaryantibodiesweredetectedwithhorseradishperoxidase– activated Sepharose 4B (Amersham Pharmacia Biotech, conjugated antirabbit antibodies (1:5000 dilution in Tris- Piscataway, NJ) in 0.1-mol/L carbonate-bicarbonate buffered saline with Tween containing 5% milk powder) and buffer (pH 11) overnight. Antiserum samples were passed an ECL detection system (Amersham Pharmacia Biotech). through the columns in a slow, regulated flow (0.5 mL/min). The columns were then washed with phosphate IMMUNOHISTOCHEMISTRY buffer and peptide-specific antibodies were eluted with Allimmunohistologicalstainingwasperformedon7-µmsec- 0.5-mol/L glycine hydrochloride buffer (pH 2.5). The elu- tions.Tissuesectionsweredewaxedinxyleneandrehydrated ants were immediately neutralized with 10% (vol/vol) throughwashesindecreasingconcentrationsofethanol(100%, Tris base buffer (pH 8.0), desalted, and concentrated with 95%,and70%).Sectionsweresubsequentlytreatedwithapro- Centriprep 30 columns (Amicon Pharmaceuticals Inc, teasecocktail(BiomedaCorp,Hayward,Calif)andavidin-biotin Beverly, Mass). and blocked with 3% normal goat serum. Sections were then incubatedwithtorsinAandBantibodies,20µg/mL,overnight PROTEIN EXTRACTION at4°C.PrimaryantibodiesweredetectedusingaVectoravidin- biotincomplexeliteperoxidasekit(VectorLaboratories,Bur- Nondenaturing Triton X-100 lysates of human trabecular lingame,Calif),enhancedbydiaminobenzidineenhancer(Bio- bone (HTB) cells were made by resuspending cell pellets medaCorp),andvisualizedwithdiaminobenzidine.Sections in ice-cold lysis buffer (100-mmol/L Tris hydrochloride, were counterstained with aqueous hematoxylin (Xymed Co, pH 7.5; 150-mmol/L sodium chloride; 5-mmol/L EDTA; 1% SanFrancisco,Calif).Alldilutionsandwasheswereperformed Triton X-100; and a cocktail of protease inhibitors). Ly- in0.1-mol/Lphosphate-bufferedsalinecontaining0.01%Tri- sates were clarified by centrifuging in a microcentrifuge at ton X-100. The specificity of immunostaining was confirmed full speed for 15 minutes. Brain homogenates were pre- by preabsorption of the primary antibodies with the specific pared as described previously.10 peptides used for immunization, 100 µmol/L. localization of normal and mutant torsin A in cultured dicted amino acid sequences of torsin proteins. Pep- cells.9 tides were chosen based on the analysis of hydrophilicity To address the discrepancies in previous studies and (Kyte-Doolittle scale), antigenic index (Jameson-Wolf to compare torsin A and torsin B protein distribution, method), and surface probability (Emini formula). The we generated and characterized torsin A– and torsin chosen peptide epitopes did not show significant homol- B–specific antibodies. Using these antibodies, we per- ogy to known proteins. Two torsin A–specific antibod- formed a comprehensive comparative analysis of the cel- ies (A1 and A2) and 1 torsin B–specific (B1) antibody lular expression of torsin A and torsin B in the human were prepared. The A1 and A2 antibodies were gener- CNS. We also made the first estimate of the molecular ated using an N-terminal (residues 51-65) and a C- weight of torsin B. terminal (residues 224-237) torsin A peptide, respec- tively. The B1 antibody was raised against an N-terminal RESULTS torsin B peptide (putative residues 77-90). Expression of torsin A and B proteins in the brain PRODUCTION AND EVALUATION was examined by Western blot analysis of whole human OF POLYCLONAL ANTIBODIES brain homogenates (Figure 1A). Analysis using A1and A2 antibodies revealed
Load more

Recommended publications
  • Candidate Chromosome 1 Disease Susceptibility Genes for Sjogren's Syndrome Xerostomia Are Narrowed by Novel NOD.B10 Congenic Mice P
    Donald and Barbara Zucker School of Medicine Journal Articles Academic Works 2014 Candidate chromosome 1 disease susceptibility genes for Sjogren's syndrome xerostomia are narrowed by novel NOD.B10 congenic mice P. K. A. Mongini Zucker School of Medicine at Hofstra/Northwell J. M. Kramer Northwell Health T. Ishikawa H. Herschman D. Esposito Follow this and additional works at: https://academicworks.medicine.hofstra.edu/articles Part of the Medical Molecular Biology Commons Recommended Citation Mongini P, Kramer J, Ishikawa T, Herschman H, Esposito D. Candidate chromosome 1 disease susceptibility genes for Sjogren's syndrome xerostomia are narrowed by novel NOD.B10 congenic mice. 2014 Jan 01; 153(1):Article 2861 [ p.]. Available from: https://academicworks.medicine.hofstra.edu/articles/2861. Free full text article. This Article is brought to you for free and open access by Donald and Barbara Zucker School of Medicine Academic Works. It has been accepted for inclusion in Journal Articles by an authorized administrator of Donald and Barbara Zucker School of Medicine Academic Works. For more information, please contact [email protected]. NIH Public Access Author Manuscript Clin Immunol. Author manuscript; available in PMC 2015 July 01. NIH-PA Author ManuscriptPublished NIH-PA Author Manuscript in final edited NIH-PA Author Manuscript form as: Clin Immunol. 2014 July ; 153(1): 79–90. doi:10.1016/j.clim.2014.03.012. Candidate chromosome 1 disease susceptibility genes for Sjogren’s syndrome xerostomia are narrowed by novel NOD.B10 congenic mice Patricia K. A. Monginia and Jill M. Kramera,1 Tomo-o Ishikawab,2 and Harvey Herschmanb Donna Espositoc aThe Feinstein Institute for Medical Research North Shore-Long Island Jewish Health System 350 Community Drive Manhasset, NY 11030 bDavid Geffen School of Medicine at UCLA 341 Boyer Hall (MBI) 611 Charles E.
    [Show full text]
  • Human Social Genomics in the Multi-Ethnic Study of Atherosclerosis
    Getting “Under the Skin”: Human Social Genomics in the Multi-Ethnic Study of Atherosclerosis by Kristen Monét Brown A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy (Epidemiological Science) in the University of Michigan 2017 Doctoral Committee: Professor Ana V. Diez-Roux, Co-Chair, Drexel University Professor Sharon R. Kardia, Co-Chair Professor Bhramar Mukherjee Assistant Professor Belinda Needham Assistant Professor Jennifer A. Smith © Kristen Monét Brown, 2017 [email protected] ORCID iD: 0000-0002-9955-0568 Dedication I dedicate this dissertation to my grandmother, Gertrude Delores Hampton. Nanny, no one wanted to see me become “Dr. Brown” more than you. I know that you are standing over the bannister of heaven smiling and beaming with pride. I love you more than my words could ever fully express. ii Acknowledgements First, I give honor to God, who is the head of my life. Truly, without Him, none of this would be possible. Countless times throughout this doctoral journey I have relied my favorite scripture, “And we know that all things work together for good, to them that love God, to them who are called according to His purpose (Romans 8:28).” Secondly, I acknowledge my parents, James and Marilyn Brown. From an early age, you two instilled in me the value of education and have been my biggest cheerleaders throughout my entire life. I thank you for your unconditional love, encouragement, sacrifices, and support. I would not be here today without you. I truly thank God that out of the all of the people in the world that He could have chosen to be my parents, that He chose the two of you.
    [Show full text]
  • The Genetics of Primary Dystonias and Related Disorders
    Brain (2002), 125, 695±721 INVITED REVIEW The genetics of primary dystonias and related disorders Andrea H. NeÂmeth The Wellcome Trust Centre for Human Genetics, Roosevelt Drive, Headington, Oxford OX3 7BN, UK E-mail: [email protected] Summary Dystonias are a heterogeneous group of disorders which dystonia (DYT1), focal dystonias (DYT7) and mixed dys- are known to have a strong inherited basis. This review tonias (DYT6 and DYT13), dopa-responsive dystonia, details recent advances in our understanding of the gen- myoclonus dystonia, rapid-onset dystonia parkinsonism, etic basis of dystonias, including the primary dystonias, Fahr disease, Aicardi±Goutieres syndrome, Haller- the `dystonia-plus' syndromes and heredodegenerative vorden±Spatz syndrome, X-linked dystonia parkin- disorders. The review focuses particularly on clinical sonism, deafness±dystonia syndrome, mitochondrial and genetic features and molecular mechanisms. dystonias, neuroacanthocytosis and the paroxysmal dys- Conditions discussed in detail include idiopathic torsion tonias/dyskinesias. Keywords: dystonia; L-dopa; parkinsonism; myoclonus; mitochondria Abbreviations: DRD = dopa-responsive dystonia; ITD = idiopathic torsion dystonia; PDJ = juvenile onset Parkinson's disease; PKC = paroxysmal kinesigenic choreoathetosis; PNKD = paroxysmal non-kinesigenic dyskinesia; TH = tyrosine hydroxylase Introduction Dystonia is a disorder of movement caused by `involuntary, (Fahn et al., 1998). Clinically, this is useful because onset of sustained muscle contractions affecting one or more sites of dystonia in the limbs, particularly the legs, is more likely to the body, frequently causing twisting and repetitive move- be associated with spread to other body parts and has ments, or abnormal postures' (Fahn et al., 1987, 1998). The important implications for treatment, management and prog- genetic contribution to the development of dystonia has been nosis, since generalized dystonia is usually much more recognized for many years, but it is only recently that some of disabling.
    [Show full text]
  • TOR1A Gene Torsin Family 1 Member A
    TOR1A gene torsin family 1 member A Normal Function The TOR1A gene (also known as DYT1) provides instructions for making a protein called torsinA. This protein is found in the space between two neighboring structures within cells, the nuclear envelope and the endoplasmic reticulum. The nuclear envelope surrounds the nucleus and separates it from the rest of the cell. The endoplasmic reticulum processes proteins and other molecules and helps transport them to specific destinations either inside or outside the cell. Although little is known about the function of torsinA, studies suggest that it may help process and transport other proteins. TorsinA may also participate in the movement of membranes associated with the nuclear envelope and endoplasmic reticulum. TorsinA is active in many of the body's tissues, and it is particularly important for the normal function of nerve cells in the brain. For example, researchers have found high levels of torsinA in a part of the brain called the substantia nigra. This region contains nerve cells that produce dopamine, a chemical messenger that transmits signals within the brain to produce smooth physical movements. Health Conditions Related to Genetic Changes Early-onset primary dystonia A particular mutation in the TOR1A gene causes most cases of early-onset primary dystonia. This mutation, which is often called the GAG deletion or delta GAG, deletes three DNA building blocks (base pairs) from the TOR1A gene. The resulting torsinA protein is missing one protein building block (amino acid) in a critical region. The altered protein's effect on the function of nerve cells in the brain is unclear.
    [Show full text]
  • Using Zebrafish As a Model System for Dyt1 Dystonia
    USING ZEBRAFISH AS A MODEL SYSTEM FOR DYT1 DYSTONIA by Jonathan Sager BS, University of Wisconsin - Oshkosh, 2006 Submitted to the Graduate Faculty of Neurobiology in partial fulfillment of the requirements for the degree of Doctor of Philosophy University of Pittsburgh 2012 UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE This dissertation was presented by Jonathan Sager It was defended on June 12th, 2012 And approved by A. Paula Monaghan-Nichols, PhD, Neurobiology Neil A. Hukriede, PhD, Microbiology and Molecular genetics Edward A. Burton, MD DPhil FRCP, Neurology Laurie Ozelius, PhD, Genetics and Genomic Sciences, Mount Sinai Hospital Committee Chair: Laura E. Lillien, PhD, Neurobiology Dissertation Advisor: Gonzalo E. Torres, PhD, Neurobiology ii Copyright © by Jonathan Sager 2012 iii USING ZEBRAFISH AS A MODEL SYSTEM FOR DYT1 DYSTONIA Jonathan Sager University of Pittsburgh, 2012 Dystonia is characterized by sustained involuntary muscle contractions producing repetitive twisting movements and abnormal postures. DYT1 dystonia, an early-onset primary dystonia, is caused by a trinucleotide deletion in the TOR1A gene, resulting in the loss of a single glutamic acid in the TorsinA protein. It is unknown how this mutation causes dysfunction of CNS motor circuits resulting in dystonia. The aims of this work were: (i) characterize the zebrafish homolog of human TOR1A in order to elucidate the functions of Torsins in vivo; (ii) generate transgenic zebrafish models of DYT1 dystonia suitable for mechanistic and drug discovery studies. An ancestral tor1 gene found in the genomes of several fish species was duplicated at the root of the tetrapod lineage. In zebrafish, tor1 is expressed as two isoforms with unique 5' exons.
    [Show full text]
  • Transcriptional Regulators Are Upregulated in the Substantia Nigra
    Journal of Emerging Investigators Transcriptional Regulators are Upregulated in the Substantia Nigra of Parkinson’s Disease Patients Marianne Cowherd1 and Inhan Lee2 1Community High School, Ann Arbor, MI 2miRcore, Ann Arbor, MI Summary neurological conditions is an established practice (3). Parkinson’s disease (PD) affects approximately 10 Significant gene expression dysregulation in the SN and million people worldwide with tremors, bradykinesia, in the striatum has been described, particularly decreased apathy, memory loss, and language issues. Though such expression in PD synapses. Protein degradation has symptoms are due to the loss of the substantia nigra (SN) been found to be upregulated (4). Mutations in SNCA brain region, the ultimate causes and complete pathology are unknown. To understand the global gene expression (5), LRRK2 (6), and GBA (6) have also been identified changes in SN, microarray expression data from the SN as familial markers of PD. SNCA encodes alpha- tissue of 9 controls and 16 PD patients were compared, synuclein, a protein found in presynaptic terminals that and significantly upregulated and downregulated may regulate vesicle presence and dopamine release. genes were identified. Among the upregulated genes, Eighteen SNCA mutations have been associated with a network of 33 interacting genes centered around the PD and, although the exact pathogenic mechanism is cAMP-response element binding protein (CREBBP) was not confirmed, mutated alpha-synuclein is the major found. The downstream effects of increased CREBBP- component of protein aggregates, called Lewy bodies, related transcription and the resulting protein levels that are often found in PD brains and may contribute may result in PD symptoms, making CREBBP a potential therapeutic target due to its central role in the interactive to cell death.
    [Show full text]
  • Quantitative Trait Loci Mapping of Macrophage Atherogenic Phenotypes
    QUANTITATIVE TRAIT LOCI MAPPING OF MACROPHAGE ATHEROGENIC PHENOTYPES BRIAN RITCHEY Bachelor of Science Biochemistry John Carroll University May 2009 submitted in partial fulfillment of requirements for the degree DOCTOR OF PHILOSOPHY IN CLINICAL AND BIOANALYTICAL CHEMISTRY at the CLEVELAND STATE UNIVERSITY December 2017 We hereby approve this thesis/dissertation for Brian Ritchey Candidate for the Doctor of Philosophy in Clinical-Bioanalytical Chemistry degree for the Department of Chemistry and the CLEVELAND STATE UNIVERSITY College of Graduate Studies by ______________________________ Date: _________ Dissertation Chairperson, Johnathan D. Smith, PhD Department of Cellular and Molecular Medicine, Cleveland Clinic ______________________________ Date: _________ Dissertation Committee member, David J. Anderson, PhD Department of Chemistry, Cleveland State University ______________________________ Date: _________ Dissertation Committee member, Baochuan Guo, PhD Department of Chemistry, Cleveland State University ______________________________ Date: _________ Dissertation Committee member, Stanley L. Hazen, MD PhD Department of Cellular and Molecular Medicine, Cleveland Clinic ______________________________ Date: _________ Dissertation Committee member, Renliang Zhang, MD PhD Department of Cellular and Molecular Medicine, Cleveland Clinic ______________________________ Date: _________ Dissertation Committee member, Aimin Zhou, PhD Department of Chemistry, Cleveland State University Date of Defense: October 23, 2017 DEDICATION I dedicate this work to my entire family. In particular, my brother Greg Ritchey, and most especially my father Dr. Michael Ritchey, without whose support none of this work would be possible. I am forever grateful to you for your devotion to me and our family. You are an eternal inspiration that will fuel me for the remainder of my life. I am extraordinarily lucky to have grown up in the family I did, which I will never forget.
    [Show full text]
  • Whole Exome Sequencing Identifies Novel DYT1 Dystonia- 2 Associated Genome Variants As Potential Disease Modifiers 3 4 Chih-Fen Hu1*, G
    bioRxiv preprint doi: https://doi.org/10.1101/2020.03.15.993113; this version posted March 18, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 1 Whole exome sequencing identifies novel DYT1 dystonia- 2 associated genome variants as potential disease modifiers 3 4 Chih-Fen Hu1*, G. W. Gant Luxton2, Feng-Chin Lee1, Chih-Sin Hsu3, Shih-Ming 5 Huang4, Jau-Shyong Hong5, San-Pin Wu6* 6 7 1 Department of Pediatrics, Tri-Service General Hospital, National Defense Medical 8 Center, Taipei, Taiwan 9 2 Department of Genetics, Cell Biology, and Development, University of Minnesota, 10 Minneapolis, MN, United States 11 3 Center for Precision Medicine and Genomics, Tri-Service General Hospital, 12 National Defense Medical Center, Taipei, Taiwan 13 4 Department and Graduate Institute of Biochemistry, National Defense Medical 14 Center, Taipei, Taiwan 15 5 Neurobiology Laboratory, National Institute of Environmental Health Sciences, 16 National Institutes of Health, Research Triangle Park, NC, United States 17 6 Reproductive and Developmental Biology Laboratory, National Institute of 18 Environmental Health Sciences, National Institutes of Health, Research Triangle 19 Park, NC, United States 20 21 * Correspondence: 22 1. Chih-Fen Hu, Department of Pediatrics, Tri-Service General Hospital, National 23 Defense Medical Center, Taipei 114, Taiwan, Email: 24 [email protected]; [email protected] 25 2. San-Pin Wu, Reproductive and Developmental Biology Laboratory, National 26 Institute of Environmental Health Sciences, National Institutes of Health, 27 Research Triangle Park, NC 27709, United States, Email: 28 [email protected] 29 30 31 32 33 Funding information: This research was funded by Tri-Service General Hospital, 34 grant number TSGH-C108-021 (C.F.H.), TSGH-C108-022 (C.F.H.) and National 35 Institutes of Health GM129374 (G.W.G.L.), Z99-ES999999 (S.P.W.).
    [Show full text]
  • WIRING of PRESYNAPTIC INHIBITORY CIRCUITRY in the MOUSE SPINAL CORD a Dissertation Presented to the Faculty of the Weill Cornell
    WIRING OF PRESYNAPTIC INHIBITORY CIRCUITRY IN THE MOUSE SPINAL CORD A Dissertation Presented to the Faculty of the Weill Cornell Graduate School of Medical Sciences in Partial Fulfillment of the Requirements for the Degree of Doctor of Philosophy By Juliet Zhang June 2016 © 2016 Juliet Zhang WIRING OF PRESYNAPTIC INHIBITORY CIRCUITRY IN THE MOUSE SPINAL CORD Juliet Zhang, Ph.D. Cornell University 2016 Proper neural circuit development, organization, and function are essential to produce correctly executed behaviors. Neural circuits in the spinal cord process sensory information, and coordinate movement. One essential circuit in the spinal cord that has been well studied is the sensory-motor reflex circuit. This circuit is subject to interneuron modulation, specifically by inhibitory GABAergic interneurons, termed GABApre neurons. GABApre neurons exert presynaptic inhibition by forming synaptic boutons on sensory afferent terminals and thereby controlling sensory signaling onto motor neurons. Previous work on GABApre neurons has identified that they express specific synaptic markers, possess stringent specificity with their sensory neuron synaptic partner, and play a role in mediating smooth movement. Deficits in presynaptic inhibition have been observed in human diseases, such as dystonia and Parkinson’s disease. GABApre neurons exert presynaptic inhibition but their molecular profile and contribution to motor disease is not well known. In this dissertation, I examine the molecular profile of GABApre neurons, and their potential link to the motor disease, dystonia. I show that the kelch-like family member 14 (Klhl14) identified from a screen for genes enriched in the intermediate spinal cord, is expressed in GABApre neurons. Klhl14 directly binds the torsin family 1, member A (Tor1a) dystonia protein, which is co-expressed in GABApre neurons.
    [Show full text]
  • Genetics of Movement Disorders and Ataxia *
    J Neurol Neurosurg Psychiatry: first published as 10.1136/jnnp.73.suppl_2.ii22 on 1 December 2002. Downloaded from GENETICS OF MOVEMENT DISORDERS AND ATAXIA Paul R Jarman, Nicholas W Wood ii22* J Neurol Neurosurg Psychiatry 2002;73(Suppl II):ii22–ii26 enetic disorders of the central nervous system have a propensity to cause movement disor- ders or ataxia, as a part of the phenotype, or sometimes as the main phenotypic manifes- Gtation. The Online Mendelian Inheritance in Man (OMIM) database lists over 500 entries for disorders of which ataxia or a movement disorder form part. Neurologists should be alert to the possibility that patients with complex disorders involving involuntary movements or unsteadiness may have a genetic disorder. Only those gene loci with relevance to the practising neurologist will be discussed; a more com- plete listing of other loci, many of which apply only to individual kindreds, is available in referenced review articles. c HUNTINGTON’S DISEASE Huntington’s disease (HD) is the prototypic neurogenetic disorder, one of the first to be mapped (1983) and subsequently cloned (1993), and the model on which presymptomatic genetic testing is based. The clinical triad of movement disorder, psychiatric features, and eventual dementia will be well known to neurologists. Chorea is the first manifestation in about two thirds of patients, initially a copyright. mild fidgetiness apparent only to the careful observer, which gradually progresses and may be the only clinical manifestation of HD for several years. Severe chorea may respond well to neuroleptics such as sulpiride. Personality change and eye movement disorders including slow saccades, and head thrusting or blinking to generate saccadic eye movements, are also common early features.
    [Show full text]
  • The TOR1A (DYT1) Gene Family and Its Role in Early Onset Torsion Dystonia Laurie J
    Genomics 62, 377–384 (1999) Article ID geno.1999.6039, available online at http://www.idealibrary.com on The TOR1A (DYT1) Gene Family and Its Role in Early Onset Torsion Dystonia Laurie J. Ozelius,*,†,1 Curtis E. Page,*,† Christine Klein,*,†,2 Jeffrey W. Hewett,*,† Mari Mineta,*,†,3 Joanne Leung,*,† Christo Shalish,*,† Susan B. Bressman,‡ Deborah de Leon,‡ Mitchell F. Brin,§ Stanley Fahn,¶ David P. Corey,ʈ,** and Xandra O. Breakefield*,†,4 *Molecular Neurogenetics Unit and ʈHoward Hughes Medical Institute, Massachusetts General Hospital, Boston, Massachusetts 02114; †Department of Neurology and Neuroscience Program and **Neurobiology Department, Harvard Medical School, Boston, Massachusetts 02115; ‡Department of Neurology, Beth Israel Medical Center, New York, New York 10003; §Movement Disorders Center, Mt. Sinai School of Medicine, New York, New York 10029; and ¶Dystonia Clinical Research Center, Department of Neurology, Columbia Presbyterian Medical Center, New York, New York 10032 Received August 13, 1999; accepted October 14, 1999 INTRODUCTION Most cases of early onset torsion dystonia are caused by a 3-bp deletion (GAG) in the coding region of the Dystonia is a movement disorder characterized by TOR1A gene (alias DYT1, DQ2), resulting in loss of a sustained muscle contractions, frequently causing glutamic acid in the carboxy terminal of the encoded twisting and repetitive movements or abnormal pos- protein, torsin A. TOR1A and its homologue TOR1B tures (Fahn et al., 1998). Over 12 different gene loci (alias DQ1) are located adjacent to each other on hu- have been implicated in various forms of primary, he- man chromosome 9q34. Both genes comprise five sim- reditary dystonia (Mueller et al., 1998; Klein et al.,in ilar exons; each gene spans a 10-kb region.
    [Show full text]
  • Commentary Mitochondria and Dystonia: the Movement Disorder
    Proc. Natl. Acad. Sci. USA Vol. 96, pp. 1817–1819, March 1999 Commentary Mitochondria and dystonia: The movement disorder connection? Douglas C. Wallace* and Deborah G. Murdock Center for Molecular Medicine, Emory University School of Medicine, Atlanta, GA 30322 Over the past 10 years, defects in mitochondrial oxidative phos- The current Proceedings paper (8) reports the function of the phorylation (OXPHOS) have been implicated in a wide variety gene responsible for the chromosome X-linked Mohr– of neurodegenerative and neuromuscular diseases. Mutations in Tranebjaerg syndrome, which presents in early childhood with the mitochondrial tRNA and mRNA genes have been associated sensory neural hearing loss that can progress to dystonia, spas- with various forms of epilepsy, spasticity (1, 2), stroke-like ticity, mental deterioration, paranoia, and cortical blindness. episodes (3, 4), and sensory neural deafness (5, 6), to mention a Those patients who develop the movement disorder character- few. One neurological symptom that has definitely been associ- istically exhibit progressive degeneration of the basal ganglia, ated with OXPHOS is the movement disorder dystonia. A corticospinal tract, and brain stem. The gene responsible for specific missense mutation in the mtDNA complex I (NADH Mohr–Tranebjaerg syndrome was identified through a patient dehydrogenase) gene, MTND6, has been linked to maternally with a deletion of the locus. The identity of the gene was inherited dystonia along with the companion phenotype, Leber’s confirmed in two additional families, one harboring a 10-bp hereditary optic neuropathy (LHON) (7). In the current issue of deletion in exon 2 and the second resulting from a 1-bp deletion these Proceedings, the association between the mitochondria and in exon 1.
    [Show full text]